There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Although studies show that diabetic kidney disease has a heritable component, searches
for the genetic determinants of this complication of diabetes have had limited success.
In this study, a new international genomics consortium, the JDRF funded Diabetic Nephropathy
Collaborative Research Initiative, assembled nearly 20,000 samples from participants
with type 1 diabetes, with and without kidney disease. The authors found 16 new diabetic
kidney disease–associated loci at genome-wide significance. The strongest signal centers
on a protective missense coding variant at COL4A3 , a gene that encodes a component
of the glomerular basement membrane that, when mutated, causes the progressive inherited
nephropathy Alport syndrome. These GWAS-identified risk loci may provide insights
into the pathogenesis of diabetic kidney disease and help identify potential biologic
targets for prevention and treatment. Although diabetic kidney disease demonstrates
both familial clustering and single nucleotide polymorphism heritability, the specific
genetic factors influencing risk remain largely unknown. To identify genetic variants
predisposing to diabetic kidney disease, we performed genome-wide association study
(GWAS) analyses. Through collaboration with the Diabetes Nephropathy Collaborative
Research Initiative, we assembled a large collection of type 1 diabetes cohorts with
harmonized diabetic kidney disease phenotypes. We used a spectrum of ten diabetic
kidney disease definitions based on albuminuria and renal function. Our GWAS meta-analysis
included association results for up to 19,406 individuals of European descent with
type 1 diabetes. We identified 16 genome-wide significant risk loci. The variant with
the strongest association (rs55703767) is a common missense mutation in the collagen
type IV alpha 3 chain ( COL4A3) gene, which encodes a major structural component
of the glomerular basement membrane (GBM). Mutations in COL4A3 are implicated in
heritable nephropathies, including the progressive inherited nephropathy Alport syndrome.
The rs55703767 minor allele (Asp326Tyr) is protective against several definitions
of diabetic kidney disease, including albuminuria and ESKD, and demonstrated a significant
association with GBM width; protective allele carriers had thinner GBM before any
signs of kidney disease, and its effect was dependent on glycemia. Three other loci
are in or near genes with known or suggestive involvement in this condition ( BMP7)
or renal biology ( COLEC11 and DDR1 ). The 16 diabetic kidney disease–associated
loci may provide novel insights into the pathogenesis of this condition and help identify
potential biologic targets for prevention and treatment.
Scalable, integrative methods to understand mechanisms that link genetic variants with phenotypes are needed. Here we derive a mathematical expression to compute PrediXcan (a gene mapping approach) results using summary data (S-PrediXcan) and show its accuracy and general robustness to misspecified reference sets. We apply this framework to 44 GTEx tissues and 100+ phenotypes from GWAS and meta-analysis studies, creating a growing public catalog of associations that seeks to capture the effects of gene expression variation on human phenotypes. Replication in an independent cohort is shown. Most of the associations are tissue specific, suggesting context specificity of the trait etiology. Colocalized significant associations in unexpected tissues underscore the need for an agnostic scanning of multiple contexts to improve our ability to detect causal regulatory mechanisms. Monogenic disease genes are enriched among significant associations for related traits, suggesting that smaller alterations of these genes may cause a spectrum of milder phenotypes.
The incidence and prevalence of diabetes mellitus have grown significantly throughout the world, due primarily to the increase in type 2 diabetes. This overall increase in the number of people with diabetes has had a major impact on development of diabetic kidney disease (DKD), one of the most frequent complications of both types of diabetes. DKD is the leading cause of end-stage renal disease (ESRD), accounting for approximately 50% of cases in the developed world. Although incidence rates for ESRD attributable to DKD have recently stabilized, these rates continue to rise in high-risk groups such as middle-aged African Americans, Native Americans, and Hispanics. The costs of care for people with DKD are extraordinarily high. In the Medicare population alone, DKD-related expenditures among this mostly older group were nearly $25 billion in 2011. Due to the high human and societal costs, the Consensus Conference on Chronic Kidney Disease and Diabetes was convened by the American Diabetes Association in collaboration with the American Society of Nephrology and the National Kidney Foundation to appraise issues regarding patient management, highlighting current practices and new directions. Major topic areas in DKD included (1) identification and monitoring, (2) cardiovascular disease and management of dyslipidemia, (3) hypertension and use of renin-angiotensin-aldosterone system blockade and mineralocorticoid receptor blockade, (4) glycemia measurement, hypoglycemia, and drug therapies, (5) nutrition and general care in advanced-stage chronic kidney disease, (6) children and adolescents, and (7) multidisciplinary approaches and medical home models for health care delivery. This current state summary and research recommendations are designed to guide advances in care and the generation of new knowledge that will meaningfully improve life for people with DKD.
Four decades have passed since the first discovery of collagen IV by Kefalides in 1966. Since then collagen IV has been investigated extensively by a large number of research laboratories around the world. Advances in molecular genetics have resulted in identification of six evolutionary related mammalian genes encoding six different polypeptide chains of collagen IV. The genes are differentially expressed during the embryonic development, providing different tissues with specific collagen IV networks each having unique biochemical properties. Newly translated alpha-chains interact and assemble in the endoplasmic reticulum in a chain-specific fashion and form unique heterotrimers. Unlike most collagens, type IV collagen is an exclusive member of the basement membranes and through a complex inter- and intramolecular interactions form supramolecular networks that influence cell adhesion, migration, and differentiation. Collagen IV is directly involved in a number of genetic and acquired disease such as Alport's and Goodpasture's syndromes. Recent discoveries have also highlighted a new and direct role for collagen IV in the development of rare genetic diseases such as cerebral hemorrhage and porencephaly in infants and hemorrhagic stroke in adults. Years of intensive investigations have resulted in a vast body of information about the structure, function, and biology of collagen IV. In this review article, we will summarize essential findings on the structural and functional relationships of different collagen IV chains and their roles in health and disease. (c) 2008 Wiley-Liss, Inc.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.